STENTYS

STENTYS

STENTYS

STENTYS products treat patients with AMI and complex coronary disease where a vessel size is ambiguous: the Self-Apposing STENTYS BMS and DES and the STENTYS AC
Founded
2006
Raised
$33.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$13,400,000
Post-IPO equity - 2016
Team Size
10+
Employees
Location
Headquarters
$13,400,000 Post-IPO equity
MassDevice

Stentys raises $13.9m to fund Euro expansion